Integra LifeSciences (IART) Stock Price & Analysis

IART$14.40+0.05 +0.35%
Medical - DevicesValue StockHigh Quality
Compare
Market cap$1.12BEnterprise value$2.80BRevenue (TTM)$1.66BMarket position—

Score

69
Bullish
Value
82
Quality
65
Growth
59

AI Analysis

Snapshot

Integra LifeSciences Holdings scores 69/100, but the multiple is asking a lot (P/E 80.7, rich vs its own history). Under the hood: P/E 80.7, rich vs its own history.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

82
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

59
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

65
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Integra LifeSciences Holdings Corporation (IART) last printed $14.40. Equity value is $1.12B. Trailing earnings multiple 86.95. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$992.08M$1.19B$1.47B$1.52B$1.37B$1.54B$1.56B$1.54B$1.61B$1.64B

About

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

Integra LifeSciences (IART) Stock Price & Analysis

IART price $14.40 +0.05 +0.35%

Ticker
IART
Price
$14.40
Change
+0.05 +0.35%
Market cap
$1.12B
P/E
86.95
Forward P/E
5.81
Dividend yield
0.00%
Beta
1.28
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
69
Value
82
Quality
65
Growth
59

Stocklytics score rationale: value 82, quality 65, growth 59.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener